SCHEMBL21801720

SCHEMBL21801720

COC1=CC(=O)c2nc(-c3cccc(OC(F)(F)F)c3)ccc2C1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP2 O95551 1/20 0.48
NSD2 O96028 1/20 0.48
XDH P47989 1/20 0.45
DYRK1A Q13627 5/20 0.42
PDE10A Q9Y233 1/20 0.41
TRPV3 Q8NET8 1/20 0.39
CTSS P25774 1/20 0.39
CTSK P43235 1/20 0.39
MAOB P27338 1/20 0.39
ATR Q13535 1/20 0.39
MAOA P21397 2/20 0.39
FYN P06241 1/20 0.38
PDE4B Q07343 1/20 0.38
ADORA2A P29274 1/20 0.38
ADORA1 P30542 1/20 0.38
IDO1 P14902 1/20 0.37
CDC25A P30304 1/20 0.37
CDC25B P30305 1/20 0.37
CLK2 P49760 1/20 0.37
HASPIN Q8TF76 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21801756 0.80 NSD2 (0.51) NSD2XDHDYRK1APDE10ATRPV3
SCHEMBL21801799 0.80 NSD2 (0.51) NSD2XDHDYRK1APDE10ATRPV3
SCHEMBL21801704 0.80 TDP2 (0.61) TDP2NSD2MAOAIDO1CDC25A
SCHEMBL21801808 0.78 XDH (0.55) XDHDYRK1APDE10ATRPV3CTSS
SCHEMBL21801902 0.78 XDH (0.41) XDHDYRK1APDE10ATRPV3CTSS
SCHEMBL21801739 0.75 TDP2 (0.47) TDP2NSD2MAOBMAOAIDO1
SCHEMBL21801793 0.73 NSD2 (0.58) TDP2NSD2MAOAIDO1CDC25A
SCHEMBL21801763 0.72 NSD2 (0.57) TDP2NSD2MAOAIDO1CDC25A
SCHEMBL10203124 0.68 XDH (0.52) XDHDYRK1ATRPV3CTSSCTSK
SCHEMBL12538473 0.67 TRPV3 (0.49) XDHDYRK1APDE10ATRPV3CTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020055192-A2 PREPARATION METHOD FOR QUINOLINE-5, 8-DIONE DERIVATIVE WHICH IS TGASE 2 INHIBITOR 재단법인 대구경북첨단의료산업진흥재단 2020-03-19 WO disclosed